Sun Pharmaceutical Industries Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is BORTEZOMIB, with a corresponding US DMF Number 28957.
Remarkably, this DMF maintains an Active status since its submission on January 20, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 03, 2015, and payment made on January 02, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II